|
|
||||||||
Receptor-Mediated Phagocytosis by HIV-1-Infected Human Monocyte-Derived Macrophages1




* AIDS Pathogenesis and Clinical Research Program, The Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia;
Helen Macpherson Smith Inflammatory Diseases Laboratory, The Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia; and
Department of Medicine, Monash University, Melbourne, Australia
Clearance of IgG-opsonized erythrocytes is impaired in HIV-1-infected patients, suggesting defective Fc
R-mediated phagocytosis in vivo. We have previously shown defective Fc
R-mediated phagocytosis in HIV-1-infected human monocyte-derived macrophages (MDM), establishing an in vitro model for defective tissue macrophages. Inhibition was associated with decreased protein expression of FcR
-chain, which transduces immune receptor signals via ITAM motifs. Fc
RI and Fc
RIIIa signal via
-chain, whereas Fc
RIIa does not. In this study, we showed that HIV-1 infection inhibited Fc
RI-, but not Fc
RIIa-dependent Syk activation in MDM, showing that inhibition was specific for
-chain-dependent signaling. HIV-1 infection did not impair
-chain mRNA levels measured by real-time PCR, suggesting a posttranscriptional mechanism of
-chain depletion. HIV-1 infection did not affect
-chain degradation (n = 7, p = 0.94) measured in metabolic labeling/chase experiments, whereas
-chain biosynthesis was inhibited (n = 12, p = 0.0068). Using an enhanced GFP-expressing HIV-1 strain, we showed that Fc
R-mediated phagocytosis inhibition is predominantly due to a bystander effect. Experiments in which MDM were infected in the presence of the antiretroviral drug 3TC suggest that active viral replication is required for inhibition of phagocytosis in MDM. These data suggest that HIV-1 infection may affect only
-chain-dependent Fc
R functions, but that this is not restricted to HIV-1-infected cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Health and Medical Research Council Program Grant 358399. E.L. is a recipient of an Australian postgraduate award, and S.M.C. of a National Health and Medical Research Council Principal Research Fellowship.
2 Address correspondence and reprint requests to Dr. Anthony Jaworowski, AIDS Pathogenesis and Clinical Research Program, The Macfarlane Burnet Institute for Medical Research and Public Health, 85 Commercial Road, Melbourne, Victoria, Australia 3004. E-mail address: anthonyj{at}burnet.edu.au
3 Abbreviations used in this paper: MDM, monocyte-derived macrophage; Ct, comparative threshold; EGFP, enhanced GFP; RT, reverse transcriptase; TLB, Triton lysis buffer.
This article has been cited by other articles:
![]() |
M. Noursadeghi, J. Tsang, R. F. Miller, S. Straschewski, P. Kellam, B. M. Chain, and D. R. Katz Genome-Wide Innate Immune Responses in HIV-1-Infected Macrophages Are Preserved Despite Attenuation of the NF-{kappa}B Activation Pathway J. Immunol., January 1, 2009; 182(1): 319 - 328. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |